The EC50 of Remifentanil Blunting Hemodynamic Response to Double Lumen Tube Intubation

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect site concentration of remifentanil blunting hemodynamic changes to tracheal intubation of single or double lumen tubes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• Patients undergoing thoracic surgery that require one lung ventilation

Exclusion Criteria:

• patient who does not agree with this study

• BMI < 16.0 or BMI > 30

• cardiovascular disease, pulmonary disease, renal disease

• alcoholic abuser or drug abuser

• patient who takes any drug to influence cardiovascular system or sympathetic nervous system

• any use of local anesthetics or drugs to influence cardiovascular system during tracheal intubation